Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System

Overview

About this study

The aim of this study is to evaluate the potential improvement in colonoscopy procedure outcomes when using the Pure-Vu System in hospitalized patients who are indicated for colonoscopy procedure.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Hospitalized patients who are indicated for a screening, diagnostic, surveillance or therapeutic colonoscopy.
  • Patients' age > 22 years.
  • Patient has signed the informed consent.

Exclusion Criteria:

  • Patients with known Inflammatory Bowel Disease and / or active Colitis.
  • Patients with active diverticulitis.
  • Patients with known or detected (during colonoscopy) bowel obstruction.
  • Patients with BMI ≤ 18 .
  • Patients with ascites Child Pugh C.
  • Patients who are 30 days post-transplant.
  • Patients treated with Peritoneal dialysis.
  • Patients under active IV inotropic medications.
  • Patients with LVAD.
  • Patients who have active anticoagulant medications (excluding aspirin) or dual antiplatelet therapy in their system prior to the procedure. (Note: to avoid exclusion therapy should be discontinued 48 hours or greater prior to the procedure based on discretion of physician).
  • Subjects with known coagulation disorder (INR ≥ 2 or platelets <50,000).
  • Subjects with hemodynamic instability.
  • Pregnancy (as stated by patient) or breast feeding.
  • Subjects with altered mental status/inability to provide informed consenPatients who have participated in another interventional clinical study in the last 2 months.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Bhaumik Brahmbhatt, M.B.B.S.

Closed for enrollment

Rochester, Minn.

Mayo Clinic principal investigator

Bhaumik Brahmbhatt, M.B.B.S.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions